Pfizer 1Q Revenues: $12.5 billion (+6%) 1Q Earnings: $3.4 billion (-16%) Comments: Worldwide pharmaceutical revenues grew 5% in the quarter to $11.6 billion. Revenue growth was driven by Lipitor, up 8% to $3.4 billion, Celebrex, up 22% to $598 million, and Lyrica, up 106% to $395 million, as well as Geodon, up 18%, Caduet, up 89%, Detrol, up 17%, Zyvox, up 39%, Vfend, up 26%, Viagra, up 11%, Zyrtec, up 10%, and Aromasin, up 33%. Also, revenues for two new products, Chantix/Champix a...